CLINICAL_TRIALS
trial_result
· 2014-05-16
Clinical Trial Update: Monthly SOM230C for Recurrent or Progressive Meningioma [Phase 2]
Summary
A Phase 2 trial evaluating monthly SOM230C (pasireotide) for recurrent or progressive meningioma has completed, with results posted in 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Patrick Y. Wen, MD | Conditions: Meningioma | Phase 2 | Status: COMPLETED | Results posted: 2014-05-16